1. Home
  2. PACB vs AIRS Comparison

PACB vs AIRS Comparison

Compare PACB & AIRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PACB
  • AIRS
  • Stock Information
  • Founded
  • PACB 2000
  • AIRS 2012
  • Country
  • PACB United States
  • AIRS United States
  • Employees
  • PACB N/A
  • AIRS N/A
  • Industry
  • PACB Biotechnology: Laboratory Analytical Instruments
  • AIRS Medical/Nursing Services
  • Sector
  • PACB Industrials
  • AIRS Health Care
  • Exchange
  • PACB Nasdaq
  • AIRS Nasdaq
  • Market Cap
  • PACB 364.2M
  • AIRS 333.7M
  • IPO Year
  • PACB 2010
  • AIRS 2021
  • Fundamental
  • Price
  • PACB $1.20
  • AIRS $2.83
  • Analyst Decision
  • PACB Buy
  • AIRS Hold
  • Analyst Count
  • PACB 10
  • AIRS 3
  • Target Price
  • PACB $2.45
  • AIRS $3.75
  • AVG Volume (30 Days)
  • PACB 6.5M
  • AIRS 506.6K
  • Earning Date
  • PACB 05-08-2025
  • AIRS 05-02-2025
  • Dividend Yield
  • PACB N/A
  • AIRS N/A
  • EPS Growth
  • PACB N/A
  • AIRS N/A
  • EPS
  • PACB N/A
  • AIRS N/A
  • Revenue
  • PACB $154,014,000.00
  • AIRS $172,101,000.00
  • Revenue This Year
  • PACB $6.13
  • AIRS N/A
  • Revenue Next Year
  • PACB $21.55
  • AIRS $5.63
  • P/E Ratio
  • PACB N/A
  • AIRS N/A
  • Revenue Growth
  • PACB N/A
  • AIRS N/A
  • 52 Week Low
  • PACB $1.06
  • AIRS $1.53
  • 52 Week High
  • PACB $2.72
  • AIRS $9.20
  • Technical
  • Relative Strength Index (RSI)
  • PACB 51.01
  • AIRS 59.75
  • Support Level
  • PACB $1.06
  • AIRS $2.02
  • Resistance Level
  • PACB $1.16
  • AIRS $3.12
  • Average True Range (ATR)
  • PACB 0.06
  • AIRS 0.33
  • MACD
  • PACB 0.01
  • AIRS 0.15
  • Stochastic Oscillator
  • PACB 73.68
  • AIRS 81.76

About PACB Pacific Biosciences of California Inc.

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.

About AIRS AirSculpt Technologies Inc.

AirSculpt Technologies Inc is a national provider of body contouring procedures delivering a premium consumer experience under its brand Elite Body Sculpture. At Elite Body Sculpture, company provide custom body contouring using proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure.

Share on Social Networks: